Exact Mass: 515.2743702
Exact Mass Matches: 515.2743702
Found 500 metabolites which its exact mass value is equals to given mass value 515.2743702,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Taurocholate
Taurocholic acid is a bile acid and is the product of the conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of taurocholate in fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and sudden intra-uterine death (PMID: 3944741, 11256973). Taurocholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=81-24-3 (retrieved 2024-07-01) (CAS RN: 81-24-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.
Taurohyocholate
Taurohyocholate is a bile acid. It is a product of the metabolism of Taurochenodeoxycholate which is catalyzed by the enzyme CYP3A4. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB] Taurohyocholate is a bile acid. It is a product of the metabolism of Taurochenodeoxycholate which is catalyzed by the enzyme CYP3A4. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). CONFIDENCE standard compound; INTERNAL_ID 268
Ciliatocholic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Candoxatril
Candoxatril is only found in individuals that have used or taken this drug. It is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure.Neutral endopeptidase inhibitors such as Candoxatril have a dual mechanism of action. They inhibit two metalloprotease enzymes, neutral endopeptidase and ACE, resulting in an increased availability of natriuretic peptides that exhibit vasodilatory effects and, possibly, tissue protective effects. D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Tauro-β-muricholic acid
Tauro-b-muricholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Tauro-b-muricholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Tauroursocholic acid
Tauroursocholic acid is a bile acid formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Tauroursocholic acid is a bile acid formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB]
Taurallocholic acid
Taurallocholic acid, also known as taurallocholate, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Taurallocholic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Taurallocholic acid is an ethanesulfonic acid derivative of cholane. An ethanesulfonic acid derivative of Cholane. Tauroallocholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. [HMDB]
LysoPC(18:4(6Z,9Z,12Z,15Z)/0:0)
LysoPC(18:4(6Z,9Z,12Z,15Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:4(6Z,9Z,12Z,15Z)), in particular, consists of one chain of stearidonic acid at the C-1 position. The stearidonic acid moiety is derived from seed oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
2-[(3alpha,7alpha,12alpha-Trihydroxy-24-oxocholane-24-yl)amino]ethanesulfonic acid
Tauro-α-muricholic acid
3-(1-((4-Carboxycyclohexyl)carbamoyl)cyclopentyl)-2-(2-methoxyethoxymethyl)propanoic acid 5-indanyl ester
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Taurocholic Acid
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.
2-[(3R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid
3alpha,7alpha,9alpha-trihydroxy-5beta-cholan-24-oic acid N-[2-sulfoethyl] amide
N-(3alpha,7alpha,15alpha-trihydroxy-5beta-cholan-24-oyl)taurine
3alpha,5,7alpha-trihydroxy-5beta-cholan-24-oic acid N-[2-sulfoethyl] amide|tauroansocholic acid
C28H37NO8_Pentanedioic acid, 2-[(6S,8aS)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxospiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-7(3H)-yl]
C28H37NO8_2-{2-[(3E)-4,8-Dimethyl-3,7-nonadien-1-yl]-3,5-dihydroxy-2-methyl-7-oxo-3,4,7,9-tetrahydropyrano[2,3-e]isoindol-8(2H)-yl}pentanedioic acid
C28H37NO8_2-[(6R,8aS)-4,6-Dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl]pentanedioic acid
C28H37NO8_Pentanedioic acid, 2-[(2R,2R,6R,8aS)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxospiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-7(3H)-yl]-, (2S)
Taurocholic Acid
A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals. D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; WBWWGRHZICKQGZ-HZAMXZRMSA-N_STSL_0093_Taurocholic acid_8000fmol_180416_S2_LC02_MS02_101; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. CONFIDENCE standard compound; INTERNAL_ID 59 Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.
(2S)-2-[(3R,7R,8R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid
Tauromuricholic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 69 CONFIDENCE standard compound; INTERNAL_ID 67 CONFIDENCE standard compound; INTERNAL_ID 65
2-{[(3Alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino}ethanesulfonic acid
BA-138-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-138-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-138-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-138-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
candoxatril
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9663; ORIGINAL_PRECURSOR_SCAN_NO 9662 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9679; ORIGINAL_PRECURSOR_SCAN_NO 9676 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9678; ORIGINAL_PRECURSOR_SCAN_NO 9675 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9724; ORIGINAL_PRECURSOR_SCAN_NO 9721 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9734; ORIGINAL_PRECURSOR_SCAN_NO 9733 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9729; ORIGINAL_PRECURSOR_SCAN_NO 9727
(2S)-2-[(3R,7R,8R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid_major
2-[(3R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid_major
2-((R)-4-((3R,5S,7R,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5R,6S,7S,9S,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5S,7R,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5R,7R,8R,9S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((4R)-4-((3R,5S,7R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
Ala Asn Arg Arg
C19H37N11O6 (515.2928142000001)
Ala Arg Asn Arg
C19H37N11O6 (515.2928142000001)
Ala Arg Arg Asn
C19H37N11O6 (515.2928142000001)
Asp Ile Ile Arg
Asp Ile Leu Arg
Asp Ile Arg Ile
Asp Ile Arg Leu
Asp Leu Ile Arg
Asp Leu Leu Arg
Asp Leu Arg Ile
Asp Leu Arg Leu
Asp Arg Ile Ile
Asp Arg Ile Leu
Asp Arg Leu Ile
Asp Arg Leu Leu
Glu Ile Arg Val
Glu Ile Val Arg
Glu Leu Arg Val
Glu Leu Val Arg
Glu Arg Ile Val
Glu Arg Leu Val
Glu Arg Val Ile
Glu Arg Val Leu
Glu Val Ile Arg
Glu Val Leu Arg
Glu Val Arg Ile
Glu Val Arg Leu
Phe Gly His Arg
Phe Gly Arg His
Phe His Gly Arg
Phe His Asn Val
Phe His Arg Gly
Phe His Val Asn
Phe Asn His Val
Phe Asn Val His
Phe Pro Pro Arg
Phe Pro Arg Pro
Phe Arg Gly His
Phe Arg His Gly
Phe Arg Pro Pro
Phe Val His Asn
Phe Val Asn His
Gly Phe His Arg
Gly Phe Arg His
Gly His Phe Arg
Gly His Arg Phe
Gly Gln Arg Arg
C19H37N11O6 (515.2928142000001)
Gly Arg Phe His
Gly Arg His Phe
Gly Arg Gln Arg
C19H37N11O6 (515.2928142000001)
Gly Arg Arg Gln
C19H37N11O6 (515.2928142000001)
His Phe Gly Arg
His Phe Asn Val
His Phe Arg Gly
His Phe Val Asn
His Gly Phe Arg
His Gly Arg Phe
His Lys Met Thr
His Lys Thr Met
His Met Lys Thr
His Met Thr Lys
His Asn Phe Val
His Asn Val Phe
His Arg Phe Gly
His Arg Gly Phe
His Thr Lys Met
His Thr Met Lys
His Val Phe Asn
His Val Asn Phe
Ile Asp Ile Arg
Ile Asp Leu Arg
Ile Asp Arg Ile
Ile Asp Arg Leu
Ile Glu Arg Val
Ile Glu Val Arg
Ile Ile Asp Arg
Ile Ile Arg Asp
Ile Lys Gln Gln
Ile Leu Asp Arg
Ile Leu Arg Asp
Ile Met Pro Arg
C22H41N7O5S (515.2889736000001)
Ile Met Arg Pro
C22H41N7O5S (515.2889736000001)
Ile Asn Asn Arg
Ile Asn Arg Asn
Ile Pro Met Arg
C22H41N7O5S (515.2889736000001)
Ile Pro Arg Met
C22H41N7O5S (515.2889736000001)
Ile Pro Thr Trp
Ile Pro Trp Thr
Ile Gln Lys Gln
Ile Gln Gln Lys
Ile Gln Gln Gln
C21H37N7O8 (515.2703482000001)
Ile Arg Asp Ile
Ile Arg Asp Leu
Ile Arg Glu Val
Ile Arg Ile Asp
Ile Arg Leu Asp
Ile Arg Met Pro
C22H41N7O5S (515.2889736000001)
Ile Arg Asn Asn
Ile Arg Pro Met
C22H41N7O5S (515.2889736000001)
Ile Arg Val Glu
Ile Thr Pro Trp
Ile Thr Trp Pro
Ile Val Glu Arg
Ile Val Arg Glu
Ile Trp Pro Thr
Ile Trp Thr Pro
Lys His Met Thr
Lys His Thr Met
Lys Ile Gln Gln
Lys Leu Gln Gln
Lys Met His Thr
Lys Met Thr His
Lys Gln Ile Gln
Lys Gln Leu Gln
Lys Gln Gln Ile
Lys Gln Gln Leu
Lys Thr His Met
Lys Thr Met His
Leu Asp Ile Arg
Leu Asp Leu Arg
Leu Asp Arg Ile
Leu Asp Arg Leu
Leu Met Pro Arg
C22H41N7O5S (515.2889736000001)
Leu Met Arg Pro
C22H41N7O5S (515.2889736000001)
Leu Asn Asn Arg
Leu Asn Arg Asn
Leu Pro Met Arg
C22H41N7O5S (515.2889736000001)
Leu Pro Arg Met
C22H41N7O5S (515.2889736000001)
Leu Pro Thr Trp
Leu Pro Trp Thr
Leu Gln Gln Gln
C21H37N7O8 (515.2703482000001)
Leu Arg Met Pro
C22H41N7O5S (515.2889736000001)
Leu Arg Asn Asn
Leu Arg Pro Met
C22H41N7O5S (515.2889736000001)
Leu Thr Pro Trp
Leu Thr Trp Pro
Leu Trp Pro Thr
Leu Trp Thr Pro
Met His Lys Thr
Met His Thr Lys
Met Ile Pro Arg
C22H41N7O5S (515.2889736000001)
Met Ile Arg Pro
C22H41N7O5S (515.2889736000001)
Met Lys His Thr
Met Lys Thr His
Met Leu Pro Arg
C22H41N7O5S (515.2889736000001)
Met Leu Arg Pro
C22H41N7O5S (515.2889736000001)
Met Pro Ile Arg
C22H41N7O5S (515.2889736000001)
Met Pro Leu Arg
C22H41N7O5S (515.2889736000001)
Met Pro Arg Ile
C22H41N7O5S (515.2889736000001)
Met Pro Arg Leu
C22H41N7O5S (515.2889736000001)
Met Arg Ile Pro
C22H41N7O5S (515.2889736000001)
Met Arg Leu Pro
C22H41N7O5S (515.2889736000001)
Met Arg Pro Ile
C22H41N7O5S (515.2889736000001)
Met Arg Pro Leu
C22H41N7O5S (515.2889736000001)
Met Thr His Lys
Met Thr Lys His
Asn Ala Arg Arg
C19H37N11O6 (515.2928142000001)
Asn Phe His Val
Asn Phe Val His
Asn His Phe Val
Asn His Val Phe
Asn Ile Asn Arg
Asn Ile Arg Asn
Asn Leu Asn Arg
Asn Leu Arg Asn
Asn Asn Ile Arg
Asn Asn Leu Arg
Asn Asn Arg Ile
Asn Asn Arg Leu
Asn Gln Arg Val
Asn Gln Val Arg
Asn Arg Ala Arg
C19H37N11O6 (515.2928142000001)
Asn Arg Ile Asn
Asn Arg Leu Asn
Asn Arg Asn Ile
Asn Arg Asn Leu
Asn Arg Gln Val
Asn Arg Arg Ala
C19H37N11O6 (515.2928142000001)
Asn Arg Val Gln
Asn Val Phe His
Asn Val His Phe
Asn Val Gln Arg
Asn Val Arg Gln
Pro Phe Pro Arg
Pro Phe Arg Pro
Pro Ile Met Arg
C22H41N7O5S (515.2889736000001)
Pro Ile Arg Met
C22H41N7O5S (515.2889736000001)
Pro Ile Thr Trp
Pro Ile Trp Thr
Pro Leu Met Arg
C22H41N7O5S (515.2889736000001)
Pro Leu Arg Met
C22H41N7O5S (515.2889736000001)
Pro Leu Thr Trp
Pro Leu Trp Thr
Pro Met Ile Arg
C22H41N7O5S (515.2889736000001)
Pro Met Leu Arg
C22H41N7O5S (515.2889736000001)
Pro Met Arg Ile
C22H41N7O5S (515.2889736000001)
Pro Met Arg Leu
C22H41N7O5S (515.2889736000001)
Pro Pro Phe Arg
Pro Pro Arg Phe
Pro Arg Phe Pro
Pro Arg Ile Met
C22H41N7O5S (515.2889736000001)
Pro Arg Leu Met
C22H41N7O5S (515.2889736000001)
Pro Arg Met Ile
C22H41N7O5S (515.2889736000001)
Pro Arg Met Leu
C22H41N7O5S (515.2889736000001)
Pro Arg Pro Phe
Pro Thr Ile Trp
Pro Thr Leu Trp
Pro Thr Trp Ile
Pro Thr Trp Leu
Pro Trp Ile Thr
Pro Trp Leu Thr
Pro Trp Thr Ile
Pro Trp Thr Leu
Gln Gly Arg Arg
C19H37N11O6 (515.2928142000001)
Gln Ile Gln Gln
C21H37N7O8 (515.2703482000001)
Gln Leu Gln Gln
C21H37N7O8 (515.2703482000001)
Gln Asn Arg Val
Gln Asn Val Arg
Gln Gln Ile Gln
C21H37N7O8 (515.2703482000001)
Gln Gln Leu Gln
C21H37N7O8 (515.2703482000001)
Gln Gln Gln Ile
C21H37N7O8 (515.2703482000001)
Gln Gln Gln Leu
C21H37N7O8 (515.2703482000001)
Gln Arg Gly Arg
C19H37N11O6 (515.2928142000001)
Gln Arg Asn Val
Gln Arg Arg Gly
C19H37N11O6 (515.2928142000001)
Gln Arg Val Asn
Gln Val Asn Arg
Gln Val Arg Asn
Arg Ala Asn Arg
C19H37N11O6 (515.2928142000001)
Arg Ala Arg Asn
C19H37N11O6 (515.2928142000001)
Arg Phe Gly His
Arg Phe His Gly
Arg Phe Pro Pro
Arg Gly Phe His
Arg Gly His Phe
Arg Gly Gln Arg
C19H37N11O6 (515.2928142000001)
Arg Gly Arg Gln
C19H37N11O6 (515.2928142000001)
Arg His Phe Gly
Arg His Gly Phe
Arg Ile Met Pro
C22H41N7O5S (515.2889736000001)
Arg Ile Asn Asn
Arg Ile Pro Met
C22H41N7O5S (515.2889736000001)
Arg Leu Met Pro
C22H41N7O5S (515.2889736000001)
Arg Leu Asn Asn
Arg Leu Pro Met
C22H41N7O5S (515.2889736000001)
Arg Met Ile Pro
C22H41N7O5S (515.2889736000001)
Arg Met Leu Pro
C22H41N7O5S (515.2889736000001)
Arg Met Pro Ile
C22H41N7O5S (515.2889736000001)
Arg Met Pro Leu
C22H41N7O5S (515.2889736000001)
Arg Asn Ala Arg
C19H37N11O6 (515.2928142000001)
Arg Asn Ile Asn
Arg Asn Leu Asn
Arg Asn Asn Ile
Arg Asn Asn Leu
Arg Asn Gln Val
Arg Asn Arg Ala
C19H37N11O6 (515.2928142000001)
Arg Asn Val Gln
Arg Pro Phe Pro
Arg Pro Ile Met
C22H41N7O5S (515.2889736000001)
Arg Pro Leu Met
C22H41N7O5S (515.2889736000001)
Arg Pro Met Ile
C22H41N7O5S (515.2889736000001)
Arg Pro Met Leu
C22H41N7O5S (515.2889736000001)
Arg Pro Pro Phe
Arg Gln Gly Arg
C19H37N11O6 (515.2928142000001)
Arg Gln Asn Val
Arg Gln Arg Gly
C19H37N11O6 (515.2928142000001)
Arg Gln Val Asn
Arg Arg Ala Asn
C19H37N11O6 (515.2928142000001)
Arg Arg Gly Gln
C19H37N11O6 (515.2928142000001)
Arg Arg Asn Ala
C19H37N11O6 (515.2928142000001)
Arg Arg Gln Gly
C19H37N11O6 (515.2928142000001)
Arg Val Asn Gln
Arg Val Gln Asn
Thr His Lys Met
Thr His Met Lys
Thr Ile Pro Trp
Thr Ile Trp Pro
Thr Lys His Met
Thr Lys Met His
Thr Leu Pro Trp
Thr Leu Trp Pro
Thr Met His Lys
Thr Met Lys His
Thr Pro Ile Trp
Thr Pro Leu Trp
Thr Pro Trp Ile
Thr Pro Trp Leu
Thr Trp Ile Pro
Thr Trp Leu Pro
Thr Trp Pro Ile
Thr Trp Pro Leu
Val Phe His Asn
Val Phe Asn His
Val His Phe Asn
Val His Asn Phe
Val Asn Phe His
Val Asn His Phe
Val Asn Gln Arg
Val Asn Arg Gln
Val Gln Asn Arg
Val Gln Arg Asn
Val Arg Asn Gln
Val Arg Gln Asn
Trp Ile Pro Thr
Trp Ile Thr Pro
Trp Leu Pro Thr
Trp Leu Thr Pro
Trp Pro Ile Thr
Trp Pro Leu Thr
Trp Pro Thr Ile
Trp Pro Thr Leu
Trp Thr Ile Pro
Trp Thr Leu Pro
Trp Thr Pro Ile
Trp Thr Pro Leu
PC(18:4/0:0)
2-((6R,8aS)-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl)pentanedioic acid
Cephalotaxine,3-[4-methyl (2R)-2-hydroxy-2-(3-methylbutyl)butanedioate]
N-(3alpha,6alpha,7beta-trihydroxy-5beta-cholan-24-oyl)-taurine
81-24-3
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.
Tauro-beta-muricholic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts A bile acid taurine conjugate derived from beta-muricholic acid. D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
2-[[(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
N5-2,4-diaminobutanoate-N1-citryl-N3-dec-2-enoyl-N3-hydroxy-1,3-diaminopropane
2-(4-acetamido-N-[2-(benzotriazol-1-yl)acetyl]anilino)-N-(2-methylbutan-2-yl)-2-(1-methylpyrrol-2-yl)acetamide
N-(3alpha,6beta,7alpha-trihydroxy-5beta-cholan-24-oyl)-taurine
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
5-(Dodecylamino)-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
2-[(4R)-4-[(2S,5R,7R,9R,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid
N-[(5S,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6S,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6R,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5S,6R,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6S,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
4-fluoro-N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-((4R)-4-((3R,5S,7R,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
2-((R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
N-[(5R,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5S,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
4-fluoro-N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-phenylphenyl)methyl]acetamide
2-((4R)-4-((3R,5S,7R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methylbenzenesulfonamide
2-[4-[(3R,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
2-[[(4R)-4-[(3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
[(1S,3R,4R,5R,6R,7S,8R,11S,13R,16R,17R)-6-hydroxy-16-(1-hydroxyethyl)-13-methoxy-5,17,19-trimethyl-14-oxo-2,15-dioxatetracyclo[9.8.0.01,7.03,8]nonadeca-9,18-dien-4-yl] 1H-pyrrole-2-carboxylate
[2-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-acetyloxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] pentanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] propanoate
2-[4-[(3R,5S,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
2-[4-[(3R,5S,7R,8R,9S,12S,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
2-[4-[(3R,5R,6R,7S,8S,9S,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
[(2R)-2-hydroxy-3-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
Nebramycin 5(5+)
An organic cation obtained by protonation of the five amino groups of nebramycin 5.
2-[4-(3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonic acid
2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
1-(9E,11E,13E,15E-octadecatetraenoyl)-sn-glycero-3-phosphocholine
phosphatidylethanolamine 20:4 zwitterion
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 20 carbons and 4 double bonds.
lysophosphatidylcholine 18:4
A lysophosphatidylcholine in which the acyl group (position not specified) contains 18 carbons and 4 double bonds.
MePC(16:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
2-({1-hydroxy-3-[(2-{[(2e,4e)-1-hydroxy-4-methylhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoyl)oxy]-2-methylbutylidene}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
C27H37N3O7 (515.2631372000001)
11-(acetyloxy)-3a,7-dihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl pyridine-3-carboxylate
(1s,3r,4r,5r,6r,7s,8r,11s,13s,16s,17r)-6-hydroxy-16-[(1r)-1-hydroxyethyl]-13-methoxy-5,17,19-trimethyl-14-oxo-2,15-dioxatetracyclo[9.8.0.0¹,⁷.0³,⁸]nonadeca-9,18-dien-4-yl 1h-pyrrole-2-carboxylate
(1r,2r,6r,10s,11r,13s,14r,15r)-13-(acetyloxy)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl 2-(dimethylamino)-3-methylbut-2-enoate
(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3s)-3-hydroxy-3-(3-methylbutyl)butanedioate
2-{4,6'-dihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl}pentanedioic acid
(2s,3s,6s)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3r)-3-hydroxy-3-(3-methylbutyl)butanedioate
n-[(1s)-1-{[(1s)-3-methanesulfinyl-1-{[(2s)-4-methyl-1-[(2r)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}-2-methylpropyl]hexanimidic acid
2-{[1-hydroxy-3-({2-[(1-hydroxy-4-methylhexa-2,4-dien-1-ylidene)amino]-3-phenylbutanoyl}oxy)-2-methylbutylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
C27H37N3O7 (515.2631372000001)